FT819 in B-cell Mediated Autoimmune Diseases
FT819-102
Phase 1 other active
Quick answer
FT819 in B-cell Mediated Autoimmune Diseases for B-cell Mediated Autoimmune Diseases is a Phase 1 program (other) at FATE THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- FATE THERAPEUTICS INC
- Indication
- B-cell Mediated Autoimmune Diseases
- Phase
- Phase 1
- Modality
- other
- Status
- active